Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study

Joint Bone Spine

Volumn 73, Issue 6, 2006, Pages 705-709

  Conrozier, Thierry ^a   Bertin, Philippe ^b   Bailleul, François ^c   Mathieu, Pierre ^d   Charlot, Jacques ^d   Vignon, Eric ^a   Treves, Richard ^b   Chevalier, Xavier ^d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c Genzyme Biosurgery Europe ^*

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Hip osteoarthritis; Hyaluronic acid; OMERACT OARSI; Osteoarthritis treatment

Indexed keywords

ACETYLSALICYLIC ACID; HEXABRIX 320 ARTHRO; HYALURONIC ACID; HYLAN G F 20; MEGLUMINE IOXAGLATE; BIOMATERIAL; DRUG DERIVATIVE; HYLAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVALUATION; FLUOROSCOPY; HIP OSTEOARTHRITIS; HUMAN; OPEN STUDY; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WALKING; FEMALE; INTRAARTICULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PILOT STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE;

AGED; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 33845568570     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.02.008     Document Type: Article

References (32)

1. Felson D.T. Epidemiology of knee and hip osteoarthritis. Epidemiol. Rev. 10 (1988) 1-18
2. Oliveria S.A., Felson D.T., Reed J.I., Cirillo P.A., and Walker A.M. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in health maintenance organizations. Arthritis Rheum. 38 (1995) 1134-1141
3. Wilson M.G., Michet C.J., Ilstrup D.M., and Melton L.J. Idiopathic symptomatic osteoarthritis of the hip and knee. A population-based incidence study. Mayo Clin. Proc. 65 (1990) 1214-1221
4. Hochberg M.C., Altman R.D., Brandt K.D., Clark B.M., Dieppe P.A., Griffin M.R., et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. Arthritis Rheum. 38 (1995) 1535-1540
5. American College of Rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and the knee. 2000 update. Arthritis Rheum. 43 (2000) 1905-1915
6. Lo G.H., La Valley M., Mc Alindon T., and Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290 (2003) 3115-3124
7. Pelletier J.P., and Martel-Pelletier J. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J. Rheumatol. 20 Suppl 39 (1993) 19-23
8. Pendleton A., Arden N., Dougados M., Doherty M., Bannwarth B., Bijlsma J.W., et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ECSISIT). Ann. Rheum. Dis. 59 (2000) 936-944
9. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P., et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann. Rheum. Dis. 62 (2003) 1145-1155
10. Scale D., Wobig M., and Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 55 (1994) 220-232
11. Wobig M., Dickhut A., Maier R., and Vetter G. Viscosupplementation with hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin. Ther. 20 (1998) 410-423
12. Dickson D.J., and Hosie G. A double blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. Journal of Clin. Research 4 (2001) 41-52
13. Qvistgaard E., Christensen R., Torp-Pedersen S., and Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 14 (2006) 163-170
14. Bragantini A., and Molinari F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res 55 (1994) 19-30
15. Brocq O., Tran G., Breueil V., Grisot C., Flory P., and Euller-Ziegler L. Hip osteoarthritis: short term efficacy of viscosupplementation by hylan GF-20. An open-label study in 22 patients. Joint Bone Spine 69 (2002) 388-391
16. Migliore A.A., Martin L.S., Alimonti A., Valente C., and Tormenta S. Efficacy and safety of viscosupplementation by ultra-sound guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11 (2003) 305-306
17. Berg P., and Olsson U. Intra-articular injection of of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheum 22 (2004) 300-306
18. Dougados M., LeClaire P., van der Heijde D., Bloch D.A., Bellamy N., and Altman R.D. Response criteria for clinical trials on osteoarthritis of the knee and hip. A report of the Osteoarthritis Research Society International standing committee for clinical trials response criteria initiative. Osteoarthritis Cartilage 8 (2000) 395-403
19. Pham T., van der Heijde D., Lassere M., Altman R., Anderson J., Bellamy N., et al. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J. Rheumatol. 30 (2003) 1648-1654
20. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 12 (2004) 389-399
21. Conrozier T., Bertin P., Mathieu P., Charlot J., Bailleul F., Trèves R., et al. Intra-articular injections of hylan GF-20 in patients with symptomatic hip osteoarthritis: an open-label, multi-centre pilot study. Clin. Exp. Rheumatol. 21 (2003) 605-610
22. Altman R., and Alarcon D. Appelrouth D and the American College of Rheumatology subcommitee on criteria for osteoarthritis. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34 (1991) 505-511
23. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteoarthrosis. Ann. Rheum. Dis. 16 (1957) 494-501
24. Lequesne M., de Sèze S., and Amouroux J. Les coxarthroses à évolution rapide. Rev. Rhum. 37 (1970) 721-733
25. Ledingham J., Dawson S., Preston B., Milligan G., and Doherty M. Radiographic patterns and associations of osteoarthritis of the hip. Ann. Rheum. Dis. 51 (1992) 1111-1116
26. Altman R., Hochberg M., Murphy W., Wolfe F., and Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage 3 Suppl A (1995) 3-70
27. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., and Stitt W.J. Validation of WOMAC. A health status instrument for measuring clinically important patient outcomes to rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J. Rheumatol. 15 (1995) 1833-1840
28. Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann. Rheum. Dis. 64 (2005) 34-37
29. Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann. Rheum. Dis. 64 (2005) 29-33
30. Ehrich E.W., Davies G.M., Watson D.J., Bolognese J.A., Seidenberg B.C., and Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and MacMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J. Rheumatol. 27 (2000) 2635-2641
31. Lussier A., Cividino A.A., Mc Farlane C., Olszynski W.P., Potashner W.J., and Medicis R. Viscosupplementation with Hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J. Rheumatol. 23 (1996) 1579-1585
32. Toh E.M., Prasad P.S., and Teanby D. Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination. Knee 9 (2002) 321-330